Full Schedule

Surgical Film: Inferior Vena Cava Resection for Recurrent Endometrial Carcinoma: Two Case Reports

Presenter: – Koc University School of Medicine

Surgical Films

Surgical Film: Laparoscopic radical trachelectomy and pelvic lymphadenectomy without uterine manipulator

Presenter: – Sun Yat-sen Memorial Hospital

Surgical Films

Surgical Film: Laparoscopic Ureteric Injury and Repair During Paraaortic Lymph Node Dissection in Endometrial Cancer: A Case Report

Presenter: – Koc University School of Medicine

Surgical Films

Surgical Film: Liver Resection at the Time of Secondary Cytoreduction in Ovarian Cancer

Presenter: – Memorial Sloan Kettering Cancer Center

Surgical Films

Surgical Film: Modified Posterior Pelvic Exenteration for Ovarian Cancer in 8 Steps

Presenter: – Sun Yat-sen Memorial Hospital

Surgical Films

Surgical Film: Posterior Robotic Exenteration with En Bloc Radical Hysterectomy, Bilateral Salpingo-oophorectomy, and VRAM Flap

Presenter: – University of South Florida

Surgical Films

Surgical Film: Radical Resection of a Retroperitoneal Tumor Involving the Inferior Vena Cava

Presenter: – The Cleveland Clinic

Surgical Films

Surgical Film: Uterine Transplant: Living Donor Surgery

Presenter: – University of Pennsylvania

Surgical Films

6:30 AM - 6:00 PM AST

Registration & Badge Pickup

7:00 AM - 6:00 PM AST

Lactation Room

Location: 202A

7:00 AM - 6:00 PM AST

Speaker Ready Room

Location: 201B

8:00 AM - 11:30 AM AST

Masterclass from Novice to Master: Conquering Coding Nuances for the Gynecologic Oncologist

Location: 209

Ticketed

8:00 AM - 8:02 AM AST

Introduction

Location: 209

Moderator: – MaineHealth

8:02 AM - 8:42 AM AST

From Codes to Compliance: Navigating the Rules, Roles, and Realities of Gynecologic Oncology Coding

Location: 209

Speaker: – Merck&Co.

8:42 AM - 9:22 AM AST

From Codes to Compliance: Navigating CMS Rules, Split Visits and Surgical Complexity

Location: 209

Speaker: – Johns Hopkins School of Medicine

9:22 AM - 9:37 AM AST

Q&A

Location: 209

Speaker: – MaineHealth

9:37 AM - 9:52 AM AST

Break

9:52 AM - 10:32 AM AST

Mastering Complex Surgical Coding 1: Case Studies in Endometrial and Cervical Malignancies

Location: 209

Speaker: – University of California, Los Angeles

10:32 AM - 11:12 AM AST

Mastering Complex Surgical Coding 2: Case Studies in Ovarian and Vulvar Malignancies

Location: 209

Speaker: – LSU Health New Orleans

11:12 AM - 11:30 AM AST

Q&A and Closing Remarks

Location: 209

Speaker: – MaineHealth

8:00 AM - 11:30 AM AST

Masterclass: SGO Early Career Summit

Location: 208

Ticketed

8:00 AM - 8:10 AM AST

Moderator Introductions & Pre-Survey

Location: 208

Moderator: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

8:10 AM - 9:10 AM AST

Panel Discussion: Threats to the Profession

Location: 208

Panelist: – University of Alabama at Birmingham

Panelist: – Moffitt Cancer Center

Panelist: – Sunnybrook Odette Cancer Centre/University of Toronto

Moderator: – Brooke Army Medical Center

9:10 AM - 10:10 AM AST

Roundtable Discussion: Different Career Paths

Location: 208

Panelist: – The Ohio State University

Panelist: – Atrium Health Wake Forest Baptist

Panelist: – Rutgers Cancer Institute

Panelist: – Baylor College of Medicine

Panelist: – Alaska Womens Cancer Care

Panelist: – GSK

Panelist: – Inova

Panelist: – Johns Hopkins Hospital

Panelist: – Duke Cancer Medical Center

Panelist: – St. Luke's University Health Network

Panelist: – Montefiore Medical Center

Panelist: – University of Texas MD Anderson Cancer Center

Panelist: – Columbia University

Moderator: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

10:10 AM - 10:20 AM AST

Break

10:20 AM - 11:25 AM AST

Leadership Panel

Location: 208

Panelist: – South Shore Hospital

Panelist: – Alaska Womens Cancer Care

Panelist: – Moffitt Cancer Center

Moderator: – Atrium Health Wake Forest Baptist

11:25 AM - 11:30 AM AST

Closing Remarks

Location: 208

Moderator: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

9:25 AM - 9:30 AM AST

Q&A

Location: Exhibit Hall A

9:00 AM - 2:00 PM AST

FWC Patient Forum

Location: Ballroom B

11:30 AM - 12:30 PM AST

Masterclass Lunch (AM & PM Sessions)

Location: 3rd Floor Terrace

12:30 PM - 4:00 PM AST

Masterclass: #HashtagThis 3.0: Technology and Advancements Using Artificial Intelligence and Social Media to Improve Patient Care and Your Gynecologic Oncology Career

Location: 209

Ticketed

12:30 PM - 12:45 PM AST

Moderator Introductions & Pre-Survey

Location: 209

Moderator: – Bay Area Gynecology Oncology

12:45 PM - 1:00 PM AST

Overview of AI in Gynecologic Oncology Part 1

Location: 209

Speaker: – University of Washington

1:00 PM - 1:15 PM AST

Overview of AI in Gynecologic Oncology Part 2

Location: 209

Speaker: – University of Iowa

1:15 PM - 1:45 PM AST

AI for Clinical Efficiency

Location: 209

Speaker:

1:45 PM - 2:00 PM AST

Break

2:00 PM - 2:15 PM AST

AI for Social Media Part 1

Location: 209

Speaker: – University of Alabama at Birmingham

2:15 PM - 2:30 PM AST

AI for Social Media Part 2

Location: 209

Speaker: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

2:30 PM - 3:00 PM AST

AI for Gyn Onc Research

Location: 209

Speaker: – Arthur Child Cancer Centre

3:00 PM - 3:15 PM AST

Break

3:15 PM - 4:00 PM AST

Panel/Q&A

Panelist: – University of Alabama at Birmingham

Panelist: – University of Iowa

Speaker:

Panelist: – Arthur Child Cancer Centre

Panelist: – University of Washington

Moderator: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

12:30 PM - 4:00 PM AST

Masterclass: Business of Medicine 2.0: Pro Tips and Practical Strategies for Clinical Efficiency and Business Optimization in Gynecologic Oncology

Location: 208

Ticketed

12:30 PM - 12:35 PM AST

Introduction

Location: 208

Moderator: – University of Alabama at Birmingham

Moderator: – University Of Pennsylvania

12:35 PM - 1:25 PM AST

Module 1: Negotiations

Location: 208

Speaker: – Johns Hopkins University School of Medicine

Speaker: – Rutgers University - New Jersey Medical

Speaker: – Columbia University

Speaker: – Roswell Park Comprehensive Cancer Center

1:25 PM - 1:35 PM AST

Break

1:35 PM - 2:15 PM AST

Module 2: Operational Efficiency

Location: 208

Speaker: – Roswell Park Comprehensive Cancer Center

Speaker: – Ohio State University James Cancer Center

2:15 PM - 3:00 PM AST

Module 3: Navigating Medical Legal Landscape

Location: 208

Speaker: – Duke University

Speaker: – Massachusetts General Hospital, Harvard Medical School

Speaker: – University of Pennsylvania

3:00 PM - 3:05 PM AST

Break

3:05 PM - 3:50 PM AST

Module 4: Sustainability and Wellness

Location: 208

Speaker: – Alaska Womens Cancer Care

Speaker: – MedStar Washington Hospital Center

Speaker: – University of Wisconsin-Madison

3:50 PM - 4:00 PM AST

Questions & Closing

12:30 PM - 4:00 PM AST

Masterclass: Peer Support Training: Tools and Techniques to Provide Care to Colleagues Following Stressful of Traumatic Events

Location: 202BC

Ticketed

12:30 PM - 12:35 PM AST

Introduction: Welcome and Objectives

Location: 202BC

Moderator: – University of Chicago

Moderator: – Mayo Clinic

Moderator: – Virginia Commonwealth University

12:35 PM - 4:00 PM AST

Peer Support Training: Tools and Techniques to Provide Care to Colleagues Following Stressful or Traumatic Events

Location: 202BC

Speaker: – Mayo Clinic

1:30 PM - 3:45 PM AST

Love, Danielle: A Film About Living with Hereditary Cancer Risk Before a Diagnosis

Location: 104

Speaker:

Ticketed

1:30 PM - 3:45 PM AST

Love, Danielle: A Film About Living with Hereditary Cancer Risk Before a Diagnosis

Location: 104

Moderator: – Weill Cornell Medicine

2:00 PM - 3:00 PM AST

Workshop: Resident/Fellow/Candidate Session

Location: 102AB

2:00 PM - 2:05 PM AST

Introduction

Location: 102AB

Moderator: – Bay Area Gynecology Oncology

Moderator: – Inova Health System, Walter Reed National Military Medical Center

2:05 PM - 2:15 PM AST

Program Directors Message

Location: 102AB

Speaker: – Mayo Clinic

Speaker: – University of Colorado, Denver

2:15 PM - 2:30 PM AST

State of the Fellowship

Location: 102AB

Speaker: – Johns Hopkins University School of Medicine

2:30 PM - 2:55 PM AST

Panel: Finding Your Niche in Gyn Onc - Following Clinical and Educational Passions

Location: 102AB

Panelist: – University of North Carolina Chapel Hill

Panelist: – University of Utah Huntsman Cancer Center

Panelist: – Cedars-Sinai Medical Center

Panelist: – The Cleveland Clinic

2:55 PM - 3:00 PM AST

Q&A

3:00 PM - 3:25 PM AST

Experiencing Grief and Training Session

Location: 102AB

Speaker: – Bay Area Gynecology Oncology

3:25 PM - 3:30 PM AST

Q&A

4:00 PM - 4:45 PM AST

Opening Ceremony

Location: Exhibit Hall A

Live Streamed

4:45 PM - 5:45 PM AST

Scientific Plenary I: Advancing Science through Clinical Trials

Location: Exhibit Hall A

Live Streamed

4:45 PM - 4:49 PM AST

Introduction

Location: Exhibit Hall A

Moderator: – MD Anderson Cancer Center

Moderator: – University of Colorado

4:49 PM - 4:57 PM AST

Final Overall Survival (OS) Results From the Phase 3 ROSELLA Trial: Relacorilant Plus Nab-Paclitaxel vs Nab-Paclitaxel Monotherapy in Patients With Platinum-Resistant Ovarian Cancer (PROC) (GOG-3073, ENGOT-ov72, APGOT-Ov10, and LACOG-0223)

Location: Exhibit Hall A

Speaker: – University of pittsburgh

LBA

4:57 PM - 5:05 PM AST

Encore: Pembrolizumab vs Placebo Plus Weekly Paclitaxel Â± Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer: Final Analysis Results from the Randomized Double-Blind Phase 3 ENGOT-ov65/KEYNOTE-B96 Study

Location: Exhibit Hall A

Speaker: – Florida Cancer Specialists and Research Institute

5:05 PM - 5:13 PM AST

Long-Term Efficacy and Safety of Avutometinib + Defactinib in Patients with Recurrent Low-Grade Serous Ovarian Cancer: Results from ENGOT-OV60/GOG-3052/RAMP 201

Location: Exhibit Hall A

Speaker: – Memorial Sloan Kettering Cancer Center

5:13 PM - 5:21 PM AST

GOG-3039: A Phase II Trial of Abemaciclib Plus Letrozole in Recurrent or Persistent Endometrioid Endometrial Carcinoma (NCT04393285)

Location: Exhibit Hall A

Speaker: – University of Virginia

5:21 PM - 5:29 PM AST

Results of a Randomized Phase III Trial of Letrozole Alone Versus Paclitaxel and Carboplatin Followed by Letrozole as Initial Treatment for Patients with Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Low-Grade Serous Carcinoma (NRG-GY019, NCT04095364)

Location: Exhibit Hall A

Speaker: – Johns Hopkins Hospital

LBA

5:29 PM - 5:39 PM AST

Distillation

Location: Exhibit Hall A

Speaker: – Memorial Sloan Kettering Cancer Center

5:39 PM - 5:45 PM AST

Q&A

5:45 PM - 7:00 PM AST

All Are Welcome Reception

Location: Exhibit Hall B

6:00 PM - 6:30 PM AST

Applications, Interviews, Program Selection, oh my!

Location: Fellows' Lounge - Exhibit Hall B

Speaker: – Mayo Clinic

Speaker: – University of Colorado, Denver

6:30 PM - 7:00 PM AST

Didn’t attend the Early Career Summit or AI Masterclass? Here’s what you Missed

Location: Fellows' Lounge - Exhibit Hall B

Speaker: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

6:30 AM - 6:00 PM AST

Registration & Badge Pickup

Location: Lobby

7:00 AM - 8:30 AM AST

ISS I: Live Tumor Board®: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer

Location: Ballroom B

7:00 AM - 8:30 AM AST

ISS II: Precision in Practice: Applying Personalized MRD testing in Gyn Onc Treatment Pathways

Location: 208

7:00 AM - 8:30 AM AST

ISS III: Advancements in Treatments for Recurrent Low-grade Serous Ovarian Cancer (LGSOC)

Location: 209

7:00 AM - 6:00 PM AST

Lactation Room

Location: 202A

7:00 AM - 6:00 PM AST

Speaker Ready Room

Location: 201B

7:30 AM - 8:30 AM AST

Coffee Break in Exhibit Hall

Location: Exhibit Hall B

7:30 AM - 7:00 PM AST

Exhibit Hall Open

Location: Exhibit Hall B

8:15 AM - 8:25 AM AST

Celebrating 35 Years of Purpose and Progress - Foundation for Women’s Cancer

Location: SGO Booth (#323)

Speaker: – Memorial Sloan-Kettering Cancer Center

8:45 AM - 9:30 AM AST

Scientific Plenary II: Transforming Endometrial Cancer Care

Location: Exhibit Hall A

Live Streamed

8:45 AM - 8:47 AM AST

Introduction

Location: Exhibit Hall A

Moderator: – Weill Cornell Medicine NY Presbyterian Hospital

Moderator: – University of Alabama at Birmingham

8:47 AM - 8:54 AM AST

Trastuzumab Pamirtecan (DB-1303/BNT323) in patients with previously treated HER2-expressing advanced/metastatic endometrial cancer: First global clinical Phase 2 data

Location: Exhibit Hall A

Speaker: – Perlmutter Cancer Center, NYU Langone

8:54 AM - 9:01 AM AST

Efficacy and safety of cadonilimab combined with chemotherapy as the first-line treatment for recurrent/advanced endometrial carcinoma: a multi-center, single-arm phase II clinical trial

Location: Exhibit Hall A

Speaker: – Fujian cancer hospital

9:01 AM - 9:08 AM AST

The social interventions for support in treatment of endometrial cancer and recurrence (SISTER) study: A national randomized controlled trial of peer support vs. usual care in Black women with high-risk endometrial cancer

Location: Exhibit Hall A

Speaker: – University of Washington

LBA

9:08 AM - 9:15 AM AST

Facilitated Genetic Cascade Testing (FaCT): A Prospective Multi-Institutional Randomized Controlled Trial

Location: Exhibit Hall A

Speaker: – The University of Texas MD Anderson Cancer Center

9:15 AM - 9:23 AM AST

Distillation

Location: Exhibit Hall A

Speaker:

9:23 AM - 9:30 AM AST

Q&A

Location: Exhibit Hall A

9:30 AM - 10:30 AM AST

Presidential Address: Karen Lu, MD

Location: Exhibit Hall A

Live Streamed

9:30 AM - 9:35 AM AST

Introduction

Location: Exhibit Hall A

Moderator: – Washington University School of Medicine

9:35 AM - 10:30 AM AST

Presidential Address

Location: Exhibit Hall A

Speaker: – Moffitt Cancer Center

10:30 AM - 11:00 AM AST

Coffee Break in Exhibit Hall

Location: Exhibit Hall B

10:30 AM - 11:00 AM AST

How to Put Yourself on the Map in Gyn Onc Social Media

Location: Fellows' Lounge - Exhibit Hall B

Speaker:

Speaker: – University of Washington

10:35 AM - 10:55 AM AST

Build the Best Smart Phrases- and Other Resources to Boost Efficiency

Location: SGO Booth (#323)

Speaker: – Baylor College of Medicine

Speaker: – University of Oklahoma, Stephenson Cancer Center

Speaker: – Cleveland Clinic

11:00 AM - 11:02 AM AST

Introduction

Location: Exhibit Hall A

Moderator: – MD Anderson Cancer Center

Moderator: – University of Colorado

11:02 AM - 11:35 AM AST

Humor & Humanity in Healthcare

Location: Exhibit Hall A

Speaker:

11:35 AM - 12:35 PM AST

Scientific Plenary III: Surgical Showdown - Farr Nezhat Session

Location: Exhibit Hall A

Live Streamed

11:35 AM - 11:37 AM AST

Introduction

Location: Exhibit Hall A

Moderator: – Houston Methodist Hospital

Moderator: – University of Chicago

11:37 AM - 11:39 AM AST

Introduction and Announcement of Surgical Film Winner

Location: Exhibit Hall A

Panelist: – NEZHAT SURGERY for Gynecology/Oncology

11:39 AM - 11:47 AM AST

Renal Vein Angle and Standardized Technique for Single-Port Laparoscopic Paraaortic Lymphadenectomy

Location: Exhibit Hall A

Surgical Film Session Speaker: – Sun Yat-sen University Cancer Center

11:47 AM - 11:56 AM AST

Laparoscopic Uterine & Ovarian Transposition with Oophoropexy and Cervical Stoma Creation

Location: Exhibit Hall A

Surgical Film Session Speaker: – The Cleveland Clinic

11:56 AM - 12:01 PM AST

Distillation

Location: Exhibit Hall A

Speaker: – Duke University, Durham, NC

12:01 PM - 12:13 PM AST

Debate - Primary Cytoreductive Surgery (PCS)

Location: Exhibit Hall A

Speaker: – Mayo Clinic

12:13 PM - 12:25 PM AST

Debate - Neoadjuvant Chemotherapy (NACT)

Location: Exhibit Hall A

Speaker: – Columbia University

12:25 PM - 12:35 PM AST

Q&A

Location: Exhibit Hall A

12:45 PM - 2:15 PM AST

ISS IV: Expert Second Opinion: Investigators Provide Perspectives on the Management of HER2-Positive Gynecologic Cancers

Location: Ballroom A

12:45 PM - 2:15 PM AST

ISS V: A Treatment Option for Certain Patients With Platinum-Resistant Ovarian Cancer

Location: Ballroom B

12:45 PM - 2:15 PM AST

ISS VI: Precision Targets, Personalized Care: Targeting DNA Damage Repair With PARP Inhibitors in Ovarian Cancer

Location: 208

12:45 PM - 2:15 PM AST

ISS VII: Expert Second Opinion: Investigators Provide Perspectives on the Best-Practice Use of Immunotherapy in Endometrial Cancer

Location: 209

2:00 PM - 3:00 PM AST

FWC Poster Walk and Coffee Chat

Location: Chrysler Conference Room

2:30 PM - 3:00 PM AST

Coffee Break in Exhibit Hall

Location: Exhibit Hall B

2:30 PM - 3:00 PM AST

Finding your People: How to get Involved with SGO as a Volunteer

Location: Fellows' Lounge - Exhibit Hall B

Speaker: – Carle Cancer Institute and the University of Illinois at Urbana Champaign

Speaker:

2:30 PM - 3:00 PM AST

We're Listening! Help Us Build the Future of SGO Wellness!

Location: SGO Booth (#323)

Speaker: – Wake Forest University School of Medicine

Speaker: – Duke University

Speaker: – University of Chicago

3:00 PM - 3:02 PM AST

Introduction

Location: Ballroom B

Moderator: – UT MD Anderson Cancer Center

Moderator: – The University of Texas MD Anderson Cancer Center

3:02 PM - 3:10 PM AST

Introduction to AI

Location: Ballroom B

Speaker: – Bay Area Gynecology Oncology

3:10 PM - 3:16 PM AST

Identification of ovarian cancer with AI analysis of CT scans

Location: Ballroom B

Speaker: – University of Iowa

3:16 PM - 3:22 PM AST

Deep Learning-Based Binary Classification of Cervical Lesions Using MobileNetV2 on Colposcopy Images: A Comparative Study

Location: Ballroom B

Speaker: – Konkuk University Hospital

3:22 PM - 3:28 PM AST

Using deep learning models to predict Homologous Recombination Deficiency (HRD) in patients with ovarian cancer based on whole slide images at 5x, 10x, 20x, and 40x magnifications

Location: Ballroom B

Speaker: – Yonsei University College Of Medicine

3:28 PM - 3:34 PM AST

Leveraging Artificial Intelligence to Streamline Documentation and Support Patient-Centered Gynecologic Oncology Outpatient Visits

Location: Ballroom B

Speaker: – University of Utah

3:34 PM - 3:40 PM AST

Can ChatGPT Take My Call? Evaluating AI in Gynecologic Oncology Telephone Triage

Location: Ballroom B

Speaker: – Icahn School of Medicine at Mount Sinai

3:40 PM - 3:48 PM AST

Distillation

Location: Ballroom B

Speaker: – Arthur Child Cancer Centre

3:48 PM - 4:00 PM AST

Q&A

Location: Ballroom B

3:00 PM - 3:02 PM AST

Introduction

Location: 209

Moderator: – Atrium Health Levine Cancer/Wake Forest School of Medicine

Moderator:

3:02 PM - 3:08 PM AST

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor

Location: 209

Speaker: – Medical College of Wisconsin

3:08 PM - 3:14 PM AST

HER2 overexpression does not impact survival in patients with stage I uterine serous carcinoma

Location: 209

Speaker: – Cedars-Sinai

3:14 PM - 3:20 PM AST

Impact of intraoperative capsule rupture on survival in early-stage clear cell ovarian carcinoma

Location: 209

Speaker: – Hospital of the University of Pennsylvania

3:20 PM - 3:28 PM AST

Distillation

Location: 209

Speaker: – University of Minnesota

3:28 PM - 3:34 PM AST

Multi-parametric MRI-based machine learning for outcome prediction in patients with vulvar squamous cell carcinoma

Location: 209

Speaker: – Fujian Cancer Hospital

3:34 PM - 3:40 PM AST

Development and Validation of A Clinically Applicable Toolkit for Cervical Gastric-Type Adenocarcinoma (GAS):Diagnostic model, Risk Stratification, and Survival Predictive Nomograms

Location: 209

Speaker: – Obstetrics and Gynecology Hospital of Fudan University

3:40 PM - 3:48 PM AST

Distillation

Location: 209

Speaker: – Memorial Sloan Kettering Cancer Center

3:48 PM - 4:00 PM AST

Q&A

Location: 209

3:00 PM - 3:02 PM AST

Introduction

Location: 208

Moderator: – The University of Texas MD Anderson Cancer Center

Moderator: – Northwestern University

3:02 PM - 3:08 PM AST

POLE mutation analysis, molecular characterization, and associations with survival outcomes: Ancillary analysis of GOG-0258

Location: 208

Speaker: – Ohio Health

3:08 PM - 3:14 PM AST

Molecular subtype assignment in endometrial carcinoma: challenging cases and the role of panel sequencing

Location: 208

Speaker: – Memorial Sloan Kettering Cancer Center

3:14 PM - 3:20 PM AST

Development and validation of prognostic biomarkers to enhance clinical triage in high-risk endometrial carcinoma

Location: 208

Speaker: – Inova

3:20 PM - 3:28 PM AST

Distillation

Location: 208

Speaker: – University of North Carolina at Chapel Hill

3:28 PM - 3:34 PM AST

ML-Driven Uterine Lavage Extracellular Vesicle Proteomics Enables Accurate, Early Detection of Endometrial Cancer

Location: 208

Speaker: – MDDx

3:34 PM - 3:40 PM AST

Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer

Location: 208

Speaker: – Duke University School of Medicine

3:40 PM - 3:48 PM AST

Distillation

Location: 208

Speaker: – Mayo Clinic

3:48 PM - 4:00 PM AST

Q&A

Location: 208

3:00 PM - 3:02 PM AST

Introduction

Location: 104

Moderator: – MD Anderson

Moderator: – Weill Cornell Medicine

3:02 PM - 3:05 PM AST

Glucagon-Like Peptide-1 Receptor Agonists Are Associated With a Reduced Cumulative Incidence of Obesity-Associated Cancers in Obese Non-Diabetic Women

Location: 104

Speaker: – Houston Methodist Hospital

3:05 PM - 3:08 PM AST

Prevalence of germline pathogenic variants in patients with endometrial cancer diagnosed before and after 65 years old within a laboratory-based research registry

Location: 104

Speaker: – UPMC

3:08 PM - 3:11 PM AST

Immunohistochemistry for mismatch repair protein expression in endometrial intraepithelial neoplasia is cost effective to diagnose Lynch Syndrome at low population prevalence

Location: 104

Speaker: – Brigham and Women's Hospital and Massachusetts General Hospital

3:11 PM - 3:14 PM AST

A randomized feasibility study of group-based education intervention for BRCA1/2 pathogenic variant carriers

Location: 104

Speaker: – MD Anderson Cancer Center

3:14 PM - 3:17 PM AST

TUBB6 Methylation in Cervical Swabs for Ovarian Cancer Detection: Primarily Performance

Location: 104

Speaker: – Tri-Service General Hospital, National Defense Medical University

3:17 PM - 3:20 PM AST

The Potential of Multi-Cancer Early Detection Tests for Reducing Cancer Mortality in Cervical, Ovarian, and Endometrial Cancers

Location: 104

Speaker: – Exact Sciences

3:20 PM - 3:30 PM AST

Distillation

Location: 104

Speaker: – UCSF Helen Diller Family Comprehensive Cancer Center

3:30 PM - 3:35 PM AST

Q&A

Location: 104

3:35 PM - 3:38 PM AST

Prognostic impact of intraoperative capsule rupture in stage I mucinous ovarian carcinoma

Location: 104

Speaker: – Hospital of the University of Pennsylvania

3:38 PM - 3:41 PM AST

Utilization and outcomes of fertility-sparing ovarian cystectomy for stage I malignant ovarian germ cell tumors

Location: 104

Speaker: – Columbia University Vagelos College of Physicians and Surgeons

3:41 PM - 3:44 PM AST

Comparing Intrathecal Morphine with Intraoperative Lidocaine Infusion to Epidural Anesthesia with Postoperative PCA for Patients Undergoing Exploratory Laparotomy: A Randomized Controlled Trial

Location: 104

Speaker: – Rush University Medical Center

3:44 PM - 3:54 PM AST

Distillation

Location: 104

Speaker: – University of Chicago

3:54 PM - 4:00 PM AST

Q&A

Location: 104

3:00 PM - 4:00 PM AST

Workshop: Amplifying Our Voice: Personal Branding and Communication Skills for Today's Platforms

Location: Ballroom A

3:02 PM - 4:00 PM AST

Panel Discussion

Location: Ballroom A

Panelist: – University of Washington

Panelist:

Panelist: – Curley Company

4:00 PM - 4:30 PM AST

Exhibit Hall & Posters

Location: Exhibit Hall B

4:00 PM - 4:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – Women's Cancer Care Associates

Moderator: – Montefiore Medical Center

4:02 PM - 4:09 PM AST

Single vs Coinfection of High-Risk Human Papillomavirus in High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer

Location: Exhibit Hall B

Poster Presenter: – Adventist Health White Memorial

Poster

4:09 PM - 4:16 PM AST

A Retrospective Cross-Sectional Study of Timely vs Not Timely Cervical Cancer Screening Rates Among Urban Women Living with HIV (WLWH) with Positive HPV Screening: CASCADE Clinical Trials Network

Location: Exhibit Hall B

Poster Presenter: – Emory University

Poster

4:16 PM - 4:23 PM AST

Awareness of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction Among Primary Care Providers: A Survey Study

Location: Exhibit Hall B

Poster Presenter: – Mayo Clinic

Poster

4:23 PM - 4:30 PM AST

Click to Know: Patient Satisfaction with Direct Electronic Medical Record Release of Genetic Test Results

Location: Exhibit Hall B

Poster Presenter: – Weill Cornell Medicine

Poster

4:00 PM - 4:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of Colorado

Moderator: – University of Wisconsin

4:02 PM - 4:09 PM AST

Clinical utility of circulating tumor DNA in cervical cancer: correlation with clinical course and guidance of management

Location: Exhibit Hall B

Poster Presenter: – maimonides medical center

Poster

4:09 PM - 4:16 PM AST

Integrating circulating tumor DNA and second-look laparoscopy for minimal residual disease detection and survival prediction in ovarian cancer

Location: Exhibit Hall B

Poster Presenter: – The University of Texas MD Anderson Cancer Center

Poster

4:16 PM - 4:23 AM AST

Ovarian cancer proteomic biomarkers for pembrolizumab response

Location: Exhibit Hall B

Poster Presenter: – Vanderbilt University Medical Center

Poster

4:00 PM - 4:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of California San Francisco

Moderator: – University of Nebraska Medical Center

4:02 PM - 4:09 PM AST

Treatment experience in patients (pts) with advanced ovarian cancer (AOC) who received PARP inhibitor (PARPi) as the first-line (1L) maintenance therapy (MTx) in the real world by homologous recombination deficiency (HRD)/BRCA status

Location: Exhibit Hall B

Poster Presenter: – Zucker School of Medicine at Hofstra / Northwell

Poster

4:09 PM - 4:16 PM AST

Differences in Age at Onset in Chinese Ovarian Cancer Patients with BRCA Germline Mutations: Implications for Timing of Risk-Reducing Surgery

Location: Exhibit Hall B

Poster Presenter: – peking university third hospital

Poster

4:16 PM - 4:23 PM AST

Metachronous breast cancer among women with ovarian cancer and germline BRCA1/2 pathogenic variants: a population-based analysis

Location: Exhibit Hall B

Poster Presenter: – MD Anderson Cancer Center

Poster

4:23 PM - 4:30 PM AST

Multimodal predictors of recurrence in patients with germline BRCA1/2-associated ovarian cancer receiving frontline PARP inhibitor maintenance

Location: Exhibit Hall B

Poster Presenter: – Memorial Sloan Kettering Cancer Center

Poster

4:00 PM - 4:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – UCSD Moores Cancer Center

Moderator: – University of Texas MD Anderson Cancer Center

4:02 PM - 4:09 PM AST

Conceptualizing Impacts of Material and Social Insecurity on Clinical Outcomes in Gynecologic Oncology: Developing an intersectional model of precarity and cancer care

Location: Exhibit Hall B

Poster Presenter: – University of New Mexico

Poster

4:09 PM - 4:16 PM AST

Equity in ADC Therapy: Real-World Outcomes Across Diverse Underrepresented Gynecologic Cancer Populations

Location: Exhibit Hall B

Poster Presenter: – Ucla

Poster

4:16 PM - 4:23 PM AST

Feasibility, acceptability, and nursing workload impact of a texting platform for remote postoperative monitoring in gynecologic oncology surgical patients

Location: Exhibit Hall B

Poster Presenter: – Hospital of the University of Pennsylvania

Poster

4:23 PM - 4:30 PM AST

Efficacy Analysis of the Randomized Pilot Clinical Trial of Neuroplasticity-Based Cognitive Training Exercises for GYNecologic Cancer-Related COGnitive Impairment (GYNCOG)

Location: Exhibit Hall B

Poster Presenter: – Northwestern University Feinberg School of Medicine

Poster

4:10 PM - 4:25 PM AST

Stronger Together: The Physician Role in Bringing APPS Into SGO

Location: SGO Booth (#323)

Speaker: – Vanderbilt Medical Center

Speaker: – Northwell Health

4:30 PM - 4:32 PM AST

Introduction

Location: Ballroom A

Moderator: – University of Florida

Moderator: – UC Davis Health

4:32 PM - 4:52 PM AST

The New Miracle Drug? GLP-1 Receptor Agonists and Cancer

Location: Ballroom A

Speaker: – The University of Tennessee Medical Center, Knoxville, TN

4:52 PM - 4:58 PM AST

The triple agonist incretin mimetic retatrutide as a novel treatment strategy for obesity-driven endometrial cancer

Location: Ballroom A

Speaker: – University of North Carolina

4:58 PM - 5:04 PM AST

Tirzepatide and Intermittent Energy Restriction have anti-obesity and anti-tumorigenic effects in a pre-clinical mouse model of obesity-driven endometrial cancer

Location: Ballroom A

Speaker: – University of North Carolina

5:04 PM - 5:10 PM AST

Impact of GLP-1 RA plus Progestin Therapy on Conservative Management of Endometrial Cancer and Endometrial Intraepithelial Neoplasia

Location: Ballroom A

Speaker: – Beth Israel Deaconess Medical Center

5:10 PM - 5:18 PM AST

Distillation

Location: Ballroom A

Speaker: – Mount Sinai Medical Center

5:18 PM - 5:30 PM AST

Q&A

Location: Ballroom A

4:30 PM - 4:52 PM AST

Introduction to Advances in Assessment of Minimal Residual Disease

Location: 208

Speaker: – MD Anderson Cancer Center

4:52 PM - 4:58 PM AST

Circulating tumor DNA in locally advanced cervical cancer: a real-world cohort study

Location: Ballroom B

Speaker: – AdventHealth

4:58 PM - 5:04 PM AST

Expanded Subtype Testing for Circulating Tumor HPV DNA Reliably Detects the Presence of Advanced-Stage and Recurrent Cervical Cancer

Location: Ballroom B

Speaker: – Northwell Health / Long Island Jewish Medical Center

5:04 PM - 5:10 PM AST

Clinical Performance of Signatera Genome Assay to Predict Treatment Response in Patients with Advanced-Stage Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Location: Ballroom B

Speaker: – University of Alabama Birmingham

LBA

5:10 PM - 5:18 PM AST

Distillation

Location: Ballroom B

Speaker: – University of California Davis

5:18 PM - 5:30 PM AST

Q&A

Location: Ballroom B

4:30 PM - 4:32 PM AST

Introduction

Location: 208

Moderator: – University of Minnesota

Moderator: – University of Colorado

4:32 PM - 4:38 PM AST

Combination of exportin-1 (XPO1) with Bcl-2/xL inhibition is synergistic in low-grade serous ovarian cancer

Location: 208

Speaker: – University of Pennsylvania, Division of Gynecologic Oncology

4:38 PM - 4:44 PM AST

Combination ATR and PARP Inhibitor (CAPRI) Trial in recurrent platinum-sensitive high-grade serous ovarian cancer demonstrates activity independent of homologous recombination repair status

Location: 208

Speaker: – University of Pennsylvania

4:44 PM - 4:50 PM AST

COPS5 Inhibition Promotes R-Loop Accumulation and Overcomes PARP Inhibitor Resistance

Speaker: – Washington University

4:50 PM - 4:58 PM AST

Distillation

Location: 208

Speaker: – The University of Colorado

4:58 PM - 5:04 PM AST

Repurposing progestins to improve efficacy of hormone therapy for endometrial cancer

Location: 208

Speaker: – University of Iowa

5:04 PM - 5:10 PM AST

Race-Associated Genomic and Transcriptomic Features and Outcomes in High-Risk Endometrial Cancer: A Cancer Moonshot and NRG Oncology/GOG-210 Study

Location: 208

Speaker: – The Ohio State University

5:10 PM - 5:18 PM AST

Distillation

Location: 208

Speaker: – University of Virginia

5:18 PM - 5:30 PM AST

Q&A

Location: 208

4:30 PM - 4:32 PM AST

Introduction

Location: 104

Moderator: – TATA MEMORIAL CENTRE

Moderator: – Washington University

4:32 PM - 4:35 PM AST

HPV Genotyping in adenocarcinoma of the cervix in patients living in Puerto Rico: Implications for Vaccine Coverage and Surveillance

Location: 104

Speaker: – University of Miami Sylvester Comprehensive Cancer Center

4:35 PM - 4:38 PM AST

Breaking the Survival Gap: Clinical Trials as Equalizers in Gynecologic Cancer Outcomes

Location: 104

Speaker: – Medical college of georgia

4:38 PM - 4:41 PM AST

Factors associated with low uptake of cervical cancer screening post-solid organ transplant

Location: 104

Speaker: – University of Minnesota

4:41 PM - 4:44 PM AST

Improving Access to Care: Physician and Advanced Practice Provider Performance in Cervical Preinvasive Disease Diagnosis

Location: 104

Speaker: – University of Alabama Birmingham

4:44 PM - 4:47 PM AST

Surgery Hurts: The Burden of Work-Related Pain and Injuries Among Gynecologic Oncologists

Location: 104

Speaker: – Stanford University

4:47 PM - 4:57 PM AST

Distillation

Location: 104

Speaker: – University of South Alabama Mitchell Cancer Institute

4:57 PM - 5:02 PM AST

Q&A

Location: 104

5:02 PM - 5:05 PM AST

Mandatory Completion of End-of-Life Forms (eMOLSTs) Reduces Inpatient Mortality in Gynecologic Oncology Patients

Location: 104

Speaker: – NYU Grossman School of Medicine

5:05 PM - 5:08 PM AST

Factors Supporting Adjuvant Treatment Escalation in High-Risk Stage I-II Endometrioid Endometrial Carcinoma: A Propensity Score Weighed Investigation

Location: 104

Speaker: – National Capital Consortium (Walter Reed National Military Medical Center, Inova Fairfax, MedStar)

5:08 PM - 5:11 PM AST

Similar Survival Outcomes Following Adjuvant Chemotherapy Versus Observation in Low-Grade, Stage I Endometrioid Ovarian, Tubal and Peritoneal Carcinoma: A Propensity Score Weighted Analysis

Location: 104

Speaker: – National Capital Consortium (Walter Reed National Military Medical Center, Inova Fairfax, MedStar)

5:11 PM - 5:14 PM AST

Prediction of Response to Fertility Preserving Progestin Therapy for Endometrial Cancer Based on Molecular Subtype

Location: 104

Speaker: – University of Toronto

5:14 PM - 5:24 PM AST

Distillation

Location: 104

Speaker: – Massachusetts General Hosptial / Harvard Medical School

5:24 PM - 5:30 PM AST

Q&A

Location: 104

4:30 PM - 5:30 PM AST

Workshop: Speed Mentoring

Location: 209

5:30 PM - 6:00 PM AST

Wellness Practices to Incorporate in a Busy Life

Location: Fellows' Lounge - Exhibit Hall B

Speaker: – Duke University

Speaker: – New York University Langone Health

5:30 PM - 7:00 PM AST

Exhibit Hall & Posters

Location: Exhibit Hall B

6:00 PM - 6:30 PM AST

The Fine Print after Fellowship

Location: Fellows' Lounge - Exhibit Hall B

Speaker:

7:30 PM - 10:30 PM AST

Social Event + FWC Fundraiser

Location: Offsite: Coca Cola Music Hall

6:30 AM - 6:00 PM AST

Registration & Badge Pickup

Location: Lobby

7:00 AM - 8:30 AM AST

ISS IX: A Treatment Approach for Certain Types of HER2+ Metastatic Solid Tumors After Prior Systemic Treatment

Location: 208

7:00 AM - 8:30 AM AST

ISS VIII: Administering an Antibody Drug Conjugate to Appropriate 2L+ Relapsed/Metastatic Cervical Cancer Patients

Location: Ballroom B

7:00 AM - 8:30 AM AST

ISS X: Breaking Barriers in Platinum-Resistant Ovarian Cancer: Novel Targets and Emerging Therapies

Location: 209

7:00 AM - 6:00 PM AST

Lactation Room

Location: 202A

7:00 AM - 6:00 PM AST

Speaker Ready Room

Location: 201B

7:30 AM - 5:00 PM AST

Exhibit Hall Open

Location: Exhibit Hall B

8:00 AM - 9:00 AM AST

Coffee Break in Exhibit Hall

Location: Exhibit Hall B

8:15 AM - 8:25 AM AST

Advancing Research Excellence - Foundation for Women’s Cancer

Location: SGO Booth (#323)

Speaker: – Foundation for Women's Cancer

8:30 AM - 9:00 AM AST

We're Listening! Help Us Build the Future of SGO Wellness!

Location: SGO Booth (#323)

Speaker: – Penn State Health

8:45 AM - 9:00 AM AST

Introduction & Overview Talk

Location: Exhibit Hall A

Speaker: – Icahn School of Medicine at Mount Sinai

Speaker: – University of Alabama at Birmingham

9:00 AM - 9:25 AM AST

Panel Discussion

Location: Exhibit Hall A

Panelist: – Emory University

Panelist: – Brigham & Women's Hospital/Dana Farber Cancer Institute

Panelist: – University Of Pennsylvania

9:25 AM - 9:30 AM AST

Q&A

Location: Exhibit Hall A

Moderator: – Icahn School of Medicine at Mount Sinai

Moderator: – University of Alabama at Birmingham

8:45 AM - 9:30 AM AST

Future of the Profession: Scope Creep or Scope Evolution? Redefining Gynecologic Oncology Sponsored by Gynecologic Oncology

Location: Exhibit Hall A

Speaker: – University of Alabama at Birmingham

Speaker: – Icahn School of Medicine at Mount Sinai

Live Streamed

8:50 AM - 9:00 AM AST

Scope Creep or Scope Evolution? Redefining Gynecologic Oncology

Speaker: – University of Alabama at Birmingham

Speaker: – Icahn School of Medicine at Mount Sinai

9:30 AM - 9:32 AM AST

Introduction

Location: Exhibit Hall A

Moderator: – Moffitt Cancer Center

9:32 AM - 10:00 AM AST

Breath by Breath: From Cancer to Everest

Location: Exhibit Hall A

Speaker:

Live Streamed

10:00 AM - 10:02 AM AST

Introduction

Location: Exhibit Hall A

Moderator: – University of California, San Francisco

Moderator: – The Ohio State University James Cancer Center

10:02 AM - 10:10 AM AST

Mocertatug rezetecan (GSK5733584), a B7-H4-targeted antibody-drug conjugate (ADC), in platinum-resistant ovarian cancer (PROC) and endometrial cancer (EC): First results from the global BEHOLD-1 study

Location: Exhibit Hall A

Speaker: – Hospital Universitario Puerta de Hierro Majadahond, Madrid

LBA

10:10 AM - 10:18 AM AST

SYS6043, a B7-H3 targeting antibody-drug conjugates in patients with advanced gynecologic cancers: a phase 1/2, first-in-human study

Location: Exhibit Hall A

Speaker: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy

10:18 AM - 10:26 AM AST

Updated results from the first-in-human phase 1 study of LY4170156, an antibody drug conjugate (ADC) targeting folate receptor alpha (FRÎ±) in recurrent platinum resistant high-grade serous ovarian cancer (HGSOC)

Location: Exhibit Hall A

Speaker: – Perlmutter Cancer Center, NYU Langone

10:26 AM - 10:34 AM AST

The pivotal PYNNACLE Phase 2 trial assessing rezatapopt, a selective p53 reactivator, in patients with advanced or metastatic solid tumors harboring a TP53 Y220C mutation: Interim analysis of patients with ovarian cancer

Location: Exhibit Hall A

Speaker: – Memorial Sloan Kettering Cancer Center

10:34 AM - 10:42 AM AST

Phase II Study of Camrelizumab plus Apatinib Combined with Chemotherapy in High-Risk, Chemoresistant Gestational Trophoblastic Neoplasia

Location: Exhibit Hall A

Speaker: – Peking Union Medical College Hospital

10:42 AM - 10:52 AM AST

Distillation

Location: Exhibit Hall A

Speaker: – Johns Hopkins Sidney Kimmel Cancer Center

10:52 AM - 11:00 AM AST

Q&A

Location: Exhibit Hall A

11:00 AM - 11:30 AM AST

From Intimidation to Influence: The Fellows Preview

Location: Fellows' Lounge - Exhibit Hall B

Speaker: – The University of Kansas Medical Center

Speaker: – Univerisity Hospitals Cleveland Medical Center

Speaker: – UMass Memorial Health

11:00 AM - 11:02 AM AST

Introduction

Location: Exhibit Hall B

Moderator: – The University of Texas MD Anderson Cancer Center

Moderator: – University of Alabama

11:02 AM - 11:09 AM AST

What will it take to make maintenance mirvetuximab soravtansine cost-effective in platinum-sensitive ovarian cancer: a threshold analysis

Location: Exhibit Hall B

Poster Presenter: – Duke University

Poster

11:09 AM - 11:16 AM AST

Survival trends in cervical cancer: A racial/ethnic comparison in the United States and Puerto Rico (2000-2021)

Location: Exhibit Hall B

Poster Presenter: – University of Puerto Rico Comprehensive Cancer Center

Poster

11:16 AM - 11:23 AM AST

Epidermic trends in female early-onset cancer: an analysis based on the Global Burden of Disease Study 1990-2021

Location: Exhibit Hall B

Poster Presenter: – Fujian cancer hospital

Poster

11:23 AM - 11:30 AM AST

Association of financial toxicity with ovarian cancer treatment and survival

Location: Exhibit Hall B

Poster Presenter: – Beth Israel Deaconess Medical Center

Poster

11:00 AM - 11:02 AM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of Alabama at Birmingham

Moderator: – Memorial Sloan Kettering Cancer Center

11:02 AM - 11:09 AM AST

Exploratory Analysis of Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Ovarian Carcinoma: Impact of Prior Therapy, Chemotherapy Exposure, and Age (GOG-3026)

Location: Exhibit Hall B

Poster Presenter: – Mount Sinai Medical Center

Poster

11:09 AM - 11:16 AM AST

Neoadjuvant Pamiparib in Newly Diagnosed Advanced Ovarian Cancer: A Single-Arm, Prospective Phase II Trial

Location: Exhibit Hall B

Poster Presenter: – Fujian Cancer Hospital

Poster

11:16 AM - 11:23 AM AST

Randomized Controlled Trial of Elenagen (Plasmid Encoding p62/SQSTM1) Plus Gemcitabine Versus Placebo Plus Gemcitabine in Patients With Platinum-Resistant Ovarian Cancer

Location: Exhibit Hall B

Poster Presenter: – McGill University Health Centre

Poster

11:00 AM - 11:02 AM AST

Introduction

Location: Exhibit Hall B

Moderator: – Nebraska Methodist Hospital

Moderator: – University of Virginia School of Medicine

11:02 AM - 11:09 AM AST

RARE CAMELLIAS: A feasibility study of a hybrid virtual platform to expand access to gynecologic oncology clinical trials in rural Louisiana

Location: Exhibit Hall B

Poster Presenter: – LSU Health New Orleans

Poster

11:09 AM - 11:16 AM AST

Growth is Good: Medicaid Expansion Positively Impacts Palliative Care and Survival in Gynecologic Cancers

Location: Exhibit Hall B

Poster Presenter: – Vanderbilt University School of Medicine

Poster

11:16 AM - 11:23 AM AST

An Opportunity to Improve HPV Vaccination Uptake among Youth: An Ob/Gyn Resident HPV Vaccination and Cervical Cancer Workshop among Local High School Students

Location: Exhibit Hall B

Poster Presenter: – University of California San Francisco School of Medicine

Poster

11:23 AM - 11:30 AM AST

Exploring the impact of 2018 Centers for Medicare & Medicaid Services National Coverage Determination of Next Generation Sequencing in Ovarian Cancer

Location: Exhibit Hall B

Poster Presenter: – University of Pennsylvania

Poster

11:00 AM - 12:00 PM AST

Exhibit Hall & Poster Tours

Location: Exhibit Hall B

11:00 AM - 12:00 PM AST

Poster Session 1

Location: Exhibit Hall B

Posters

11:15 AM - 11:35 AM AST

Build the Best Smart Phrases- and Other Resources to Boost Efficiency

Location: SGO Booth (#323)

Speaker: – Baylor College of Medicine

Speaker: – University of Oklahoma, Stephenson Cancer Center

Speaker: – Cleveland Clinic

11:30 AM - 11:32 AM AST

Introduction

Location: Exhibit Hall B

Moderator: – Ochsner Cancer Institute

Moderator: – Cleveland Clinic

11:32 AM - 11:39 AM AST

Hyperthermic intraperitoneal chemotherapy improves overall survival after cytoreduction in low-grade serous ovarian cancer

Location: Exhibit Hall B

Poster Presenter: – University of South Florida

Poster

11:39 AM - 11:46 AM AST

Long Term Follow Up for Cisplatin with or without Paclitaxel During Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Epithelial Ovarian Cancer at Interval Debulking Surgery (IDS)

Location: Exhibit Hall B

Poster Presenter: – The Cleveland Clinic

Poster

11:46 AM - 11:53 AM AST

From Prediction to Action: Simple Rules from a Preoperative Model to Guide MIS Conversion Risk in Advanced Ovarian Cancer

Location: Exhibit Hall B

Poster Presenter: – MD Anderson Cancer Center

Poster

11:53 AM - 12:00 PM AST

The association between allostatic load at the time of ovarian cancer debulking surgery and patient outcomes

Location: Exhibit Hall B

Poster Presenter: – Roswell Park Comprehensive Cancer Center

Poster

11:30 AM - 11:32 AM AST

Introduction

Location: Exhibit Hall B

Moderator:

Moderator: – University of Chicago

11:32 AM - 11:39 AM AST

Readability of Gynecologic Cancer Patient Education Materials From National Cancer Institute Designated Cancer Centers and Non-Profit Organizations

Location: Exhibit Hall B

Poster Presenter: – University of Minnesota

Poster

11:39 AM - 11:46 AM AST

Exercise interventions during and after the treatment of gynecologic cancers: A systematic review of randomized trials

Location: Exhibit Hall B

Poster Presenter: – University of Arizona, College of Medicine - Phoenix

Poster

11:46 AM - 11:53 AM AST

Patient-oncologist discordance in prognosistic understanding for patients with advanced or recurrent gynecologic cancer

Location: Exhibit Hall B

Poster Presenter: – Rush University

Poster

11:53 AM - 12:00 PM AST

Missed conversations: Gaps in sexual health counseling for premenopausal cervical cancer patients undergoing chemoradiation

Location: Exhibit Hall B

Poster Presenter: – NYU Langone Health

Poster

11:30 AM - 11:32 AM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of Colorado

Moderator: – University of California, San Francisco

11:32 AM - 11:39 AM AST

LBA: Immunogenomic determinants of response to immune checkpoint inhibition in ovarian cancer: Insights from the NRG-GY003 clinical trial

Location: Exhibit Hall B

Speaker: – Icahn School of Medicine at Mount Sinai

LBA

11:39 AM - 11:46 AM AST

Targeting The IGF2BP3/MUC1/HIF-1α/Eno1 m6ADependent Metabolic Axis: A Novel Therapeutic Strategy In Endometrial Cancer

Location: Exhibit Hall B

Poster Presenter: – Fujian cancer hospital

Poster

11:46 AM - 11:53 AM AST

Tumor-targeted delivery of a VEGF-binding RNA aptamer by Listeria improves survival in a mouse model of ovarian cancer

Location: Exhibit Hall B

Poster Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine

Poster

11:53 AM - 12:00 PM AST

High and stable MUC16 expression in endometrial cancer highlights potential for targeted antibody-drug conjugate development

Location: Exhibit Hall B

Poster Presenter: – Fred and Pamela Buffett Cancer Center at the University of Nebraska

Poster

11:45 AM - 12:00 PM AST

The Power of Lived Experience - Foundation for Women’s Cancer

Location: SGO Booth (#323)

Speaker:

12:00 PM - 12:02 PM AST

Introduction

Location: Ballroom A

Moderator: – Mayo Clinic

Moderator: – H.Lee Moffitt Cancer Center

12:02 PM - 12:08 PM AST

National utilization trends and efficacy of adjuvant treatment in low-grade endometrioid endometrial cancer patients with low volume lymph node metastases

Location: Ballroom A

Speaker: – University of Florida College of Medicine

12:08 PM - 12:14 PM AST

Adjuvant dostarlimab with pelvic radiation (RT) in locally advanced, mismatch repair-deficient (MMR-D) endometrial cancer (EC): D-RT Study

Location: Ballroom A

Speaker: – Memorial Sloan Kettering Cancer Center

12:14 PM - 12:20 PM AST

Primary results from the phase 2 endomERA study of giredestrant for patients with grade 1 endometrioid endometrial cancer

Location: Ballroom A

Speaker: – Mcgill University Health Centre, McGill University

12:20 PM - 12:28 PM AST

Distillation

Location: Ballroom A

Speaker: – The Ohio State University

12:28 PM - 12:34 PM AST

Four-year survival outcomes with dostarlimab plus chemotherapy in dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

Location: Ballroom A

Speaker: – Washington University School of Medicine

12:34 PM - 12:40 PM AST

Molecular Sub group and post immunotherapy Analysis: Results from NRG GY012

Location: Ballroom A

Speaker: – Sunnybrook Odette Cancer Centre/University of Toronto

12:40 PM - 12:48 PM AST

Distillation

Location: Ballroom A

Speaker: – Memorial Sloan Kettering Cancer Center

12:48 PM - 1:00 PM AST

Q&A

Location: Ballroom A

12:00 PM - 12:02 PM AST

Introduction

Location: 208

Moderator: – Cedars-Sinai Medical Center

Moderator: – The Southeast Permanente Medical Group

12:02 PM - 12:08 PM AST

Building Trust Through Community Partnerships: Improving Knowledge and Confidence in Clinical Trials Among African American and Hispanic Women

Location: 208

Speaker: – Northwestern

12:08 PM - 12:14 PM AST

Primary HPV Testing: A Cost-Saving, Equitable, and High-Impact Strategy for Cervical Cancer Screening in Underserved Populations

Location: 208

Speaker: – The University of Texas Health Science Center at Houston

12:14 PM - 12:20 PM AST

Barriers to Equity: Policy and System Gaps in Biomarker-Driven Gynecologic Cancer Trials Across the U.S.

Location: 208

Speaker: – Johns Hopkins University

12:20 PM - 12:28 PM AST

Distillation

Location: 208

Speaker: – Rutgers NJMS Newark

12:28 PM - 12:34 PM AST

Disparities in RVU Compensation Between Gynecologic Oncology and Surgical Oncology: Is There Structural Undervaluation?

Location: 208

Speaker: – University of Alabama Birmingham

12:34 PM - 12:40 PM AST

Gender and Geographic Disparity in Industry Payments to Gynecologic Oncologists in the United States

Location: 208

Speaker: – McGill University Health Centre

12:40 PM - 12:48 PM AST

Distillation

Location: 208

Speaker: – University Of Pennsylvania

12:48 PM - 1:00 PM AST

Q&A

Location: 208

12:00 PM - 12:02 PM AST

Introduction

Location: 104

Moderator: – Princess Margaret Hospital

Moderator: – University of Puerto Rico School of Medicine

12:02 PM - 12:05 PM AST

Integrated Single-cell Profiling Identifies TNFAIP3 as a Lactylation-Driven Regulator of Chemoresistance in Ovarian Cancer

Location: 104

Speaker: – Fudan University Shanghai Cancer Center

12:05 PM - 12:08 PM AST

Impact of CCNE1 amplification on progression-free and overall survival among patients with newly diagnosed ovarian cancer without a BRCA mutation

Location: 104

Speaker: – Memorial Sloan Kettering Cancer Center

12:08 PM - 12:11 PM AST

Profiling the Immune Repertoire in a Phase II Trial of Niraparib and Dostarlimab in Recurrent or Persistent Uterine Serous Carcinomas

Location: 104

Speaker: – The Ohio State University

12:11 PM - 12:14 PM AST

Combination of carboplatin and CHK1 inhibition to overcome platinum resistance in high grade serous ovarian cancer in preclinical mouse models

Location: 104

Speaker: – University of South Alabama, Mitchell Cancer Institute

12:14 PM - 12:24 PM AST

Distillation

Location: 104

Speaker: – University of California, San Diego

12:24 PM - 12:31 PM AST

Q&A

Location: 104

12:31 PM - 12:34 PM AST

Mirvetuximab soravtansine plus carboplatin in folate receptor alpha-expressing recurrent platinum-sensitive ovarian cancer

Location: 104

Speaker: – Dept. Of Medicine, UCLA

LBA

12:34 PM - 12:37 PM AST

Comprehensive Profiling of antibody-drug conjugate (ADC) Targets Reveals Histology-Specific and Co-Expression Patterns in Endometrial Carcinoma

Location: 104

Speaker: – Saitama Medical University International Medical Center

12:37 PM - 12:40 PM AST

A global, phase 1/2 study of DB1311/BNT324 (a novel B7H3 ADC) monotherapy in patients with previously treated advanced cervical cancer or platinum-resistant recurrent ovarian cancer: Outcomes by prior treatment

Location: 104

Speaker: – Wayne State University

12:40 PM - 12:43 PM AST

Epigenetic drivers of FOLR expression in high grade serous carcinoma

Location: 104

Speaker: – University of Colorado Anschutz Medical Campus

12:43 PM - 12:53 PM AST

Distillation

Location: 104

Speaker: – The University of Oklahoma Health Sciences Center

12:53 PM - 1:00 PM AST

Q&A

Location: 104

12:00 PM - 12:05 PM AST

Introduction

Location: Ballroom B

Moderator: – University of Colorado

12:05 PM - 12:10 PM AST

Onramp

Location: Ballroom B

Speaker: – Holy Cross Hospital in Fort Lauderdale

12:10 PM - 12:20 PM AST

ADAPT (ADA)

Location: Ballroom B

12:20 PM - 12:25 PM AST

Demo Part 1

Location: Ballroom B

Speaker: – University of Colorado

Speaker: – Holy Cross Hospital in Fort Lauderdale

12:25 PM - 12:35 PM AST

ADAPT (PT)

Location: Ballroom B

Speaker: – University of Colorado, Denver

12:35 PM - 12:45 PM AST

Demo Part 2

Location: Ballroom B

Speaker: – University of Colorado

Speaker: – Holy Cross Hospital in Fort Lauderdale

12:45 PM - 12:55 PM AST

Pitfalls

Location: Ballroom B

Speaker: – University of Colorado

Speaker: – Holy Cross Hospital in Fort Lauderdale

Speaker: – University of Colorado, Denver

12:55 PM - 1:00 PM AST

Closing Remarks

Location: Ballroom B

12:00 PM - 12:02 PM AST

Introduction

Location: 209

Moderator: – Montefiore Medical Center

12:02 PM - 12:05 PM AST

Audience Poll

Location: 209

Speaker: – Rutgers - NJMS

12:05 PM - 12:15 PM AST

Challenges and opportunities with screening: The Puerto Rico story

Location: 209

Speaker: – University of Puerto Rico School of Medicine, University of Puerto Rico Comprehensive Cancer Center

12:15 PM - 12:27 PM AST

Leveraging Your Registry through the NCDB Cervix Cancer Quality Measure

Location: 209

Speaker: – UCSF Helen Diller Family Comprehensive Cancer Center

Speaker: – University of Alabama at Birmingham

12:27 PM - 12:39 PM AST

Global perspective: What's working well

Location: 209

Speaker: – Memorial Sloan Kettering Monmouth

12:37 PM - 12:49 PM AST

Equitable Implementation: Redesigning Cervical Cancer Care Pathways

Location: 209

Speaker: – Rutgers NJMS Newark

12:49 PM - 1:00 PM AST

Q&A

Location: 209

1:30 PM - 3:00 PM AST

ISS XI: Expert Second Opinion: Investigators Provide Perspectives on the Best-Practice Management of Ovarian Cancer

Location: Ballroom A

1:30 PM - 3:00 PM AST

ISS XII: A Treatment Option for Patients With Primary Advanced or Recurrent Endometrial Cancer

Location: Ballroom B

1:30 PM - 3:00 PM AST

ISS XIII: Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer

Location: 208

1:30 PM - 3:00 PM AST

ISS XIV: Data + Perspectives: The Potential Role of TROP2- and CDH6-Directed Antibody-Drug Conjugates in Gynecologic Cancers

Location: 209

1:30 PM - 4:30 PM AST

KSGO/JSGO/SGO Joint Session: Ovarian Cancer

Location: 102AB

1:30 PM - 1:35 PM AST

Welcome & Introduction

Location: 102AB

Moderator:

Moderator: – UC Davis Health

Moderator: – Seoul National University Bundang Hospital

1:35 PM - 1:55 PM AST

PDS vs. NAC-IDS (TRUST trial)

Location: 102AB

Speaker: – Memorial Sloan-Kettering Cancer Center

1:55 PM - 2:15 PM AST

Robotic debulking for advanced ovarian cancer

Location: 102AB

Speaker: – Center of Hope Reno

2:15 PM - 2:30 PM AST

HIPEC for advanced ovarian cancer

Location: 102AB

Speaker: – Ajou University Hospital

2:30 PM - 2:40 PM AST

Discussion

Location: 102AB

Speaker:

Speaker: – Yonsei University College Of Medicine

Speaker:

Speaker: – University of South Florida

2:40 PM - 2:55 PM AST

Break & Group Photo

2:55 PM - 3:15 PM AST

Prioritizing: PARPi, ICI, Bev, ADC

Location: 102AB

Speaker: – Saitama Medical University International Medical Center

3:15 PM - 3:35 PM AST

Elahere in Real World: USA

Location: 102AB

Speaker: – Inova Schar Cancer Institute

3:35 PM - 3:45 PM AST

Discussion

Location: 102AB

Speaker: – Korea University College of Medicine Guro Hospital

Speaker: – Sung Kyun Kwan University of Medicine

Speaker:

Speaker: – Konkuk University Hospital

3:45 PM - 3:55 PM AST

Break

Location: 102AB

3:55 PM - 4:30 PM AST

Tumor Board

Location: 102AB

Speaker: – Seoul National University College of Medicine

Speaker: – National Cancer Center Hospital

3:00 PM - 3:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – City of Hope

Moderator: – Dana-Farber Cancer Insitute

3:02 PM - 3:09 PM AST

Feasibility and Adherence to Cognitive Training in Gynecologic Cancer Patients with Cancer-Related Cognitive Impairment

Location: Exhibit Hall B

Poster Presenter: – Northwestern University Feinberg School of Medicine

Poster

3:09 PM - 3:16 PM AST

Real-world safety profile and clinical management of patients (pts) with epithelial ovarian cancer (EOC) who received first-line maintenance (1LM) niraparib therapy: final results from the 1NSPIRE chart review study

Location: Exhibit Hall B

Poster Presenter: – Indiana University

Poster

3:16 PM - 3:23 PM AST

All Welcome: Age and Frailty Do Not Impact Mirvetuximab Safety or Efficacy

Location: Exhibit Hall B

Poster Presenter: – The Ohio State University

Poster

3:23 PM - 3:30 PM AST

Elevated Uterine Cancer Incidence Among Women with Intellectual and Developmental Disabilities: Insights into Gynecologic Cancer Inequities

Location: Exhibit Hall B

Poster Presenter: – The Catholic University Of Korea

Poster

3:00 PM - 3:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of Virginia

Moderator: – Roswell Park Comprehensive Cancer Center

3:02 PM - 3:09 PM AST

PTEN as a biomarker for sensitivity to multitargeted small molecule CDK4/6-CDK9-AURKA/B inhibitor, LCI133, and other CDK9 inhibitors

Location: Exhibit Hall B

Poster Presenter: – Levine Cancer Institute, Atrium Health

Poster

3:09 PM - 3:16 PM AST

Performance of an extracellular vesicle and particle (EVP) based ovarian cancer (OC) screening test in average risk postmenopausal woman up to 3 years prior to clinical diagnosis

Location: Exhibit Hall B

Poster Presenter: – Mercy Bioanalytics

Poster

3:16 PM - 3:23 PM AST

Relacorilant plus nab-paclitaxel demonstrates a progression-free survival benefit in ovarian cancer independent of tumor glucocorticoid receptor (GR) expression levels

Location: Exhibit Hall B

Presenter: – University of pittsburgh

Poster

3:23 PM - 3:30 PM AST

Higher allostatic load is associated with reduced overall survival in women with epithelial ovarian cancer

Location: Exhibit Hall B

Poster Presenter: – University of Pittsburgh School of Medicine

Poster

3:00 PM - 3:30 PM AST

Surgical Film Tour Group: Surgical Video Walk

Location: SGO Booth (#323)

Surgical Films

3:00 PM - 3:02 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – The Cleveland Clinic

3:02 PM - 3:16 PM AST

Minimally Invasive Vascular Injury Repair: An Educational Video Series

Location: Exhibit Hall B

Surgical Film Tour Presenter: – Duke University

3:16 PM - 3:30 PM AST

Laparoscopic Radical Hysterectomy with Internal Iliac Vessel Resection and Ureteral Reimplantation for Low-Grade Endometrial Stromal Sarcoma

Location: Exhibit Hall B

Surgical Film Tour Presenter: – McGill University

3:00 PM - 5:00 PM AST

Exhibit Hall | Poster Tours | Surgical Film Tour

Location: Exhibit Hall B

3:30 PM - 4:00 PM AST

Vibe Shifting our Medical Vibe Coding: Theory and Context Behind our Billing and Coding System

Location: Fellows' Lounge - Exhibit Hall B

Speaker:

3:40 PM - 4:00 PM AST

Building the Next Decade Together: Policy, Coding, and Quality

Location: SGO Booth (#323)

Speaker: – Penn State Hershey Medical Center

3:45 PM - 3:47 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – University Of Pennsylvania

Moderator: – University of Arkansas for Medical Sciences

3:47 PM - 3:54 PM AST

Overutilization of laboratory studies on paracentesis and thoracentesis specimens in patients with gynecologic malignancies: An opportunity to reduce waste and cost from unindicated laboratory testing

Location: Exhibit Hall B

Poster Presenter: – Cedars Sinai

Poster

3:54 PM - 4:01 PM AST

30- and 90-day percutaneous nephrostomy (PCN) tube associated complications in patients with locally advanced, metastatic, or recurrent cervical cancer

Location: Exhibit Hall B

Poster Presenter: – University of Texas Southwestern

Poster

4:01 PM - 4:08 PM AST

Temporal trends in the cost of adverse events (AEs) in patients with primary advanced or recurrent endometrial cancer (pA/R EC) in the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial

Location: Exhibit Hall B

Poster Presenter: – Women and Infants Hospital Brown University

Poster

4:08 PM - 4:15 PM AST

Efficacy and safety of fam-trastuzumab deruxtecan in recurrent HER2-positive endometrial cancer

Location: Exhibit Hall B

Poster Presenter: – Memorial Sloan Kettering Cancer Center

Poster

3:45 PM - 3:47 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – The Cleveland Clinic Foundation

Moderator: – Duke University, Durham, NC

3:47 PM - 3:54 PM AST

Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery

Location: Exhibit Hall B

Poster Presenter: – University of Wisconsin - Madison

Poster

3:54 PM - 4:01 PM AST

Rationale and Study Design of the KOV-HIPEC-02R (RECOVER):A Randomized, Multicenter, Open-label Phase III trial of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Platinum-Resistant Recurrent

Location: Exhibit Hall B

Poster Presenter: – National Cancer Center

Poster

4:01 PM - 4:08 PM AST

Laparoscopic Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer: LANCE Randomized Clinical Trial

Location: Exhibit Hall B

Poster Presenter: – MD Anderson Cancer Center

Poster

4:08 PM - 4:15 PM AST

The BHFS Study (Better, Harder, Faster, Stronger): Does Neoadjuvant Chemotherapy Improve Fitness for Surgery?

Location: Exhibit Hall B

Poster Presenter: – Atrium Health Wake Forest Baptist

Poster

4:00 PM - 4:45 PM AST

Poster Session 2

Location: Exhibit Hall B

Posters

4:10 PM - 4:30 PM AST

HABE you heard of health equity? A presentation from the Healthcare Access, Belonging & Engagement Committee

Location: SGO Booth (#323)

Speaker: – Women's Cancer Care Associates

Speaker: – University of Miami

4:30 PM - 4:32 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of North Carolina School of Medicine

Moderator: – Brigham & Women's Hospital/Dana Farber Cancer Institute

4:32 PM - 4:39 PM AST

A phase 3, randomized, open-label study of trastuzumab deruxtecan versus standard-of-care chemotherapy as adjuvant treatment for patients with HER2-expressing (IHC 3+/2+) endometrial cancer: DESTINY-Endometrial02 (DEâ€‘02)

Location: Exhibit Hall B

Poster Presenter: – Women & Infants Hospital/Brown University

Poster

4:39 PM - 4:46 PM AST

GOG-3119/ENGOT-en29/TroFuse-033: A Phase 3, Randomized Study of Sacituzumab Tirumotecan Plus Pembrolizumab vs Pembrolizumab Alone as First-Line Maintenance Therapy for Mismatch Repair-Proficient Endometrial Cancer

Location: Exhibit Hall B

Poster Presenter: – Florida Cancer Specialists and Research Institute

Poster

4:46 PM - 4:53 PM AST

[Encore] Randomized phase III study of first-line (1L) trastuzumab deruxtecan (T-DXd) with rilvegostomig or pembrolizumab in patients with HER2-expressing, mismatch repair-proficient (pMMR), primary advanced or recurrent endometrial cancer

Location: Exhibit Hall B

Poster Presenter: – Memorial Sloan Kettering Cancer Center

Poster

4:53 PM - 5:00 PM AST

Sapanisertib and serabelisib (PIKTOR) with paclitaxel, and an insulin-suppressing diet (ISD) substudy, in patients with advanced/recurrent endometrial cancer (EC): GOG-3111

Location: Exhibit Hall B

Poster Presenter: – Mount Sinai Medical Center

Poster

4:30 PM - 4:32 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – Dana-Farber Cancer Institute

4:32 PM - 4:39 PM AST

Torvutatug samrotecan (AZD5335) vs mirvetuximab soravtansine gynx in high FRÎ± expressing tumors and torvutatug samrotecan vs chemotherapy in low FRÎ± expressing tumors in patients with platinum resistant epithelial ovarian cancer in the randomized Phase III TREVI OC 01/GOG 3127/ENGOT ov93 trial

Location: Exhibit Hall B

Poster Presenter: – European Institute of Oncology

Poster

4:39 PM - 4:46 PM AST

RAINFOL-04 (ENGOT-OV96/GOG-3134): A phase 3, open-label, randomized study of rinatabart sesutecan plus standard of care (SOC) vs SOC as maintenance treatment after second-line platinum-based chemotherapy in patients with recurrent platinum-sensitive ovarian cancer

Location: Exhibit Hall B

Poster Presenter: – University Hospital Leuven, KU Leuven

Poster

4:46 PM - 4:53 PM AST

A Phase 1/2 study of REGN5668, a MUC16×CD28 costimulatory bispecific antibody, in combination with other targeted therapies, in patients with recurrent ovarian or endometrial cancer: Trial in progress update

Location: Exhibit Hall B

Poster Presenter: – Memorial Sloan Kettering Cancer Center

Poster

4:53 PM - 5:00 PM AST

BELLA: a phase 2 study of relacorilant plus nab-paclitaxel +/- bevacizumab in patients with gynecologic cancers

Location: Exhibit Hall B

Poster Presenter: – Humanitas San Pio X Hospital

Poster

4:30 PM - 4:32 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – University of Alabama at Birmingham

Moderator: – Inova Schar Cancer Institute

4:32 PM - 4:39 PM AST

Phase I Clinical Trial Assessing the Safety and Feasibility of Intramuscular pNGVL4a-CRTE6E7L2 and TA-CIN Administration for the Treatment of Patients with HPV16+ Atypical Squamous Cells of Unknown Significance (ASC-US) or Low-Grade Squamous Intraepithelial Lesion (LSIL)

Location: Exhibit Hall B

Poster Presenter: – University of Alabama at Birmingham

Poster

4:39 PM - 4:46 PM AST

A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPVAssociated Cancers

Location: Exhibit Hall B

Poster Presenter: – Rutgers Cancer Institute

Poster

4:46 PM - 4:53 PM AST

A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers

Location: Exhibit Hall B

Poster Presenter: – Rutgers Cancer Institute

Poster

4:53 PM - 5:00 PM AST

A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGrid Electroporation Delivery System to Patients with HPV16+ High-Grade Cervical Intraepithelial NeoplasiaÂ

Location: Exhibit Hall B

Poster Presenter: – Johns Hopkins University

Poster

4:30 PM - 4:32 PM AST

Introduction

Location: Exhibit Hall B

Moderator: – MD Anderson Cancer Center

Moderator: – Memorial Sloan Kettering Cancer Center

4:32 PM - 4:39 PM AST

Combination targeted and Hormonal treAtMEnt of Low-gradE serous Ovarian cancer in the upfroNt setting (CHAMELEON)

Location: Exhibit Hall B

Poster Presenter: – Emory University School Of Medicine

Poster

4:39 PM - 4:46 PM AST

Obrixtamig (BI 764532) in patients with relapsed/refractory delta-like ligand 3 (DLL3)-high expressing extrapulmonary neuroendocrine carcinoma (epNEC): trial in progress of the dose-expansion part of the phase II DAREON-5 trial

Location: Exhibit Hall B

Poster Presenter: – Boehringer Ingelheim

Poster

4:46 PM - 4:53 PM AST

A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women with Recurrent Gynecologic Carcinosarcoma

Location: Exhibit Hall B

Poster Presenter: – University of Alabama at Birmingham

Poster

4:40 PM - 4:55 PM AST

SGO Resources You May Not Know About: A Quick Tour for Trainees & Early-Career Members

Location: SGO Booth (#323)

Speaker: – McGaw Medical Center of Northwestern University

Speaker: – Inova Health System, Walter Reed National Military Medical Center

Speaker: – Northwestern University Feinberg School of Medicine

5:00 PM - 5:30 PM AST

Transition Break | Tumor Board Bar Open

Location: Exhibit Hall A

5:30 PM - 7:00 PM AST

Tumor Board

Location: Exhibit Hall A

Live Streamed

7:00 PM - 9:00 PM AST

Alumni Events & Receptions

Location: Various Locations

6:30 AM - 12:00 PM AST

Registration & Badge Pickup

Location: Lobby

7:00 AM - 11:00 AM AST

Speaker Ready Room

Location: 201B

7:00 AM - 12:00 PM AST

Lactation Room

Location: 202A

7:30 AM - 9:00 AM AST

ISS XV: Show Me the Data®: Evolving Standards and New Frontiers in Ovarian Cancer

Location: Ballroom B

7:30 AM - 9:00 AM AST

ISS XVI: Navigating the Winds of Progress: Plotting a Course for Immunotherapy in Endometrial Cancer

Location: 209

7:30 AM - 9:00 AM AST

ISS XVII: Lynparza Trivia Challenge: How well do you know the Maintenance Therapy Landscape in Advanced Ovarian Cancer?

Location: 208

9:00 AM - 9:30 AM AST

Transition Break

9:30 AM - 9:32 AM AST

Introduction

Location: Ballroom B

Moderator: – University of Puerto Rico School of Medicine, University of Puerto Rico Comprehensive Cancer Center

Moderator: – H. Lee Moffitt Cancer Center

9:32 AM - 9:38 AM AST

Rinatabart sesutecan (Rina-S) plus bevacizumab (BEV) for patients (pts) with recurrent ovarian cancer (OC): First disclosure from cohort D2 of the phase 1/2 RAINFOL-01 study

Location: Ballroom B

Speaker: – Women & Infants Hospital/Brown University

9:38 AM - 9:44 AM AST

Sacituzumab Tirumotecan (Sac-TMT) Plus Pembrolizumab Maintenance Therapy in Ovarian Cancer: Results From the Phase 2 2870-002/SKB264-II-06 Study

Location: Ballroom B

Speaker: – Oncology Department, Fudan University Shanghai Cancer Center

9:44 AM - 9:52 AM AST

Distillation

Location: Ballroom B

Speaker: – Rutgers Cancer Institute

9:52 AM - 9:58 AM AST

Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2- expressing solid tumors: DESTINY-PanTumor02 (DP-02) Part 1 final analysis

Location: Ballroom B

Speaker: – Memorial Sloan Kettering Cancer Center

9:58 AM - 10:04 AM AST

A Multicenter, Open-Label, Phase I/II Study of IBI130, a TROP2-Targeting Antibody-Drug Conjugate, as Monotherapy in Patients with Recurrent or Metastatic Cervical Cancer

Location: Ballroom B

Speaker: – Fujian Cancer Hospital

10:04 AM - 10:12 AM AST

Distillation

Location: Ballroom B

Speaker: – H. Lee Moffitt Cancer Center

10:12 AM - 10:30 AM AST

Q&A

Location: Ballroom B

9:30 AM - 9:32 AM AST

Introduction

Location: 209

Moderator: – Bay Area Gynecology Oncology

Moderator: – Spectrum Health

9:32 AM - 9:38 AM AST

Age at ovarian cancer diagnosis varies by lynch syndrome gene: a genetic testing laboratory registry study

Location: 209

Speaker: – Memorial Sloan Kettering Cancer Center

9:38 AM - 9:44 AM AST

Hormone Replacement Therapy Following Oophorrectomy and Breast Cancer Risk in BRCA Pathogenic Variant Carriers

Location: 209

Speaker: – Carmel Medical Center

9:44 AM - 9:50 AM AST

ACT-ON: Assisted Cascade Testing via Outreach and Navigation - Real-world experience with clinician-facilitated cascade testing

Location: 209

Speaker: – Weill Cornell Medicine

9:50 AM - 9:58 AM AST

Distillation

Location: 209

Speaker: – Washington University School of Medicine

9:58 AM - 10:04 AM AST

Impact of Concomitant Hysterectomy on Quality of Life in BRCA Pathogenic Variant Carriers Undergoing Risk-Reducing Salpingo-Oophorectomy

Location: 209

Speaker: – Carmel Medical Center

10:04 AM - 10:10 AM AST

IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment): A Feasibility Randomized Trial

Location: 209

Speaker: – Vanderbilt University Medical Center

10:10 AM - 10:18 AM AST

Distillation

Location: 209

Speaker: – Icahn School of Medicine at Mount Sinai

10:18 AM - 10:30 AM AST

Q&A

Location: 209

9:30 AM - 9:32 AM AST

Introduction

Location: 208

Moderator: – Instituto Nacional de Cancerologia

Moderator: – Memorial Sloan Kettering Cancer Center

9:32 AM - 9:35 AM AST

Patient-reported outcomes from the phase 3 ENGOT-ov65/KEYNOTE-B96 trial of pembrolizumab versus placebo plus paclitaxel, with or without bevacizumab, in platinum-resistant recurrent ovarian cancer

Location: 208

Speaker: – Roswell Park Comprehensive Cancer Center

LBA

9:35 AM - 9:38 AM AST

Combination PP2A inhibition and PD-1 blockade with LB-100 and dostarlimab in ovarian clear cell carcinoma

Location: 208

Speaker: – The University of Texas MD Anderson Cancer Center

LBA

9:38 AM - 9:41 AM AST

Immune-related adverse effects in gynecologic oncology patients on pembrolizumab: trial evidence vs real-world experience

Location: 208

Speaker: – University of Michigan

9:41 AM - 9:44 AM AST

Patient-reported outcomes from the final analysis of the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: results from the homologous recombination-deficien

Location: 208

Speaker: – The Ohio State University

9:44 AM - 9:47 AM AST

Effect of adjuvant treatment after secondary cytoreductive surgery in patients with recurrent granulosa cell tumor

Location: 208

Speaker: – MD Anderson Cancer Center

9:47 AM - 9:57 AM AST

Distillation

Location: 208

Speaker: – Washington University in St. Louis

9:57 AM - 10:02 AM AST

Q&A

Location: 208

10:02 AM - 10:05 AM AST

Beyond Sedlis: Validation of histology-specific risk factors for stage I cervical squamous cell carcinoma and adenocarcinoma

Location: 208

Speaker: – Erlanger Hospital

10:05 AM - 10:08 AM AST

Phase 1b/2a randomized, double-blind study demonstrates potential of ABI-2280, a novel antiviral vaginal insert for the treatment of persistent high-risk/oncogenic HPV infection

Location: 208

Speaker: – University of Alabama at Birmingham

10:08 AM - 10:11 AM AST

Pathologic response to hypofractionation in locally advanced cervical cancer

Location: 208

Speaker: – Instituto Nacional de Cancerologia

10:11 AM - 10:14 AM AST

Prognostic significance of distant lymph node metastases alone in stage IVB cervical cancer

Location: 208

Speaker: – Hospital of the University of Pennsylvania

10:14 AM - 10:24 AM AST

Distillation

Location: 208

Speaker: – David Geffen School of Medicine at UCLA

10:24 AM - 10:30 AM AST

Q&A

Location: 208

9:30 AM - 9:35 AM AST

Introduction

Location: 104

Moderator: – University Of Pennsylvania

9:35 AM - 9:40 AM AST

SGO Government Relations Accomplishments over the past 3 years: Committee Highlights

Location: 104

Speaker: – Penn State Hershey Medical Center

9:40 AM - 9:48 AM AST

CRD Recorded Video

Location: 104

Speaker: – Penn State Hershey Medical Center

9:48 AM - 9:58 AM AST

Advocacy Tools and Strategies

Location: 104

Speaker: – Univerisity Hospitals Cleveland Medical Center

9:58 AM - 10:08 AM AST

From Intimidation to Influence

Location: 104

Speaker: – The University of Kansas Medical Center

10:08 AM - 10:22 AM AST

Hands-on: What would you do?

Location: 104

Speaker: – UMass Memorial Health

Speaker:

10:22 AM - 10:27 AM AST

From Session to Action: Your First Steps

Location: 104

Speaker: – University Of Pennsylvania

10:27 AM - 10:30 AM AST

Wrap-up and Closing

Location: 104

Moderator: – Penn State Hershey Medical Center

10:30 AM - 10:45 AM AST

Transition Break

10:45 AM - 11:15 AM AST

Business Meeting/Member Forum

Location: Exhibit Hall A

11:15 AM - 12:15 PM AST

Scientific Plenary V: Emerging Strategies in Cervical Cancer Care

Location: Exhibit Hall A

11:15 AM - 11:17 AM AST

Introduction

Location: Ballroom A

Moderator: – University of Alabama at Birmingham

Moderator: – The Cleveland Clinic

11:19 AM - 11:27 AM AST

Sacituzumab Tirumotecan (Sac-TMT) Plus Pembrolizumab in Participants With Recurrent or Metastatic Cervical Cancer: Results From the Phase 2 2870-002/SKB264-II-06 Study

Location: Exhibit Hall A

Speaker: – Oncology Department, Fudan University Shanghai Cancer Center

11:27 AM - 11:35 AM AST

Tisotumab vedotin in combination with carboplatin and pembrolizumab with or without bevacizumab in first-line recurrent or metastatic cervical cancer: first disclosure of arm H from the ENGOT-cx8/GOG-3024/innovaTV 205 study

Location: Exhibit Hall A

Speaker: – University Hospital Leuven, KU Leuven

11:35 AM - 11:43 AM AST

Development of ENG–Targeted CAR T cells for cervical cancer: Direct tumor targeting and microenvironment modulation

Location: Exhibit Hall A

Speaker: – City of Hope National Medical Center

11:43 AM - 11:51 AM AST

Exclusion of Individuals with HIV from Cervical Cancer Clinical Trials: Lack of Progress in the Immunotherapy Era

Location: Exhibit Hall A

Speaker: – Rutgers New Jersey Medical School

11:51 AM - 12:01 PM AST

Distillation

Location: Exhibit Hall A

Speaker: – University of California;Los Angeles

12:01 PM - 12:15 PM AST

Q&A

Location: Exhibit Hall A

12:15 PM - 12:30 PM AST

Closing Ceremony

Location: Exhibit Hall A

Live Streamed